Study Conduct

ERT granted patents on clinical trial participant compliance

Tuesday, July 17, 2012 02:42 PM

Philadelphia-based ERT, a global technology-driven provider of health outcomes services to sponsors and CROs, has received two additional patents from the U.S. Patent and Trademark Office (U.S. Patent No. 8,065,180 and U.S. Patent No. 8,145,519).  The patents are titled System for Clinical Trial Subject Compliance and were acquired by ERT as part of its recent acquisition of invivodata.

More... »

23andMe acquires CureTogether

Thursday, July 12, 2012 11:22 AM

Personal genetics company 23andMe has completed its first acquisition with the purchase of CureTogether, launched in 2008 to help people who live in daily chronic pain.

More... »

OncoSec establishes UCSF clinical site for phase II Merkel cell carcinoma trial

Wednesday, July 11, 2012 10:22 AM

OncoSec Medical, a biopharmaceutical company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, has established the University of California San Francisco (UCSF) as the second enrolling site for its phase II Merkel cell carcinoma study (OMS-I110).

More... »

CRI Lifetree opens new early stage research facility

Tuesday, July 10, 2012 10:23 AM

CRI Lifetree, a specialized, multi-therapeutic early stage research company focused on pain, human abuse liability, psychiatry, neurology and diabetes, has opened a new state-of-the-art research facility in Marlton, N.J. The new site raises the company’s total bed count to 250 and adds capacity to conduct complex clinical trials.

More... »

Medidata-sponsored study identifies up to $5B in potential trial cost savings

Wednesday, June 27, 2012 03:37 PM

The results of a new research study performed by the Center for the Study of Drug Development at Tufts University School of Medicine and sponsored by Medidata Solutions, a global provider of cloud-based clinical development solutions, found that clinical data gathered from 25% of the procedures administered to patients may be unnecessary—and, in the aggregate, are responsible for $3-5 billion in overall clinical trial costs annually.

More... »

Vodafone, Exco InTouch partner to develop patient reported outcomes solution

Wednesday, June 27, 2012 02:45 PM

Vodafone, a mobile communications company, has signed an agreement with Exco InTouch, a provider of compliant, interactive mobile patient management solutions, to deliver Vodafone Patient Reported Outcomes (Vodafone PRO), a solution that has the potential to improve patient compliance and data quality in clinical research.

More... »

BBK Worldwide website redefines purchase of patient recruitment products and services

Wednesday, June 27, 2012 12:29 PM

BBK Worldwide has launched shop.BBKWorldwide.com, which provides clinical research professionals an online resource where they can learn about, and purchase, a full range of patient recruitment products and services.

More... »

ePharmaSolutions to acquire global patient recruitment firm Polaris BioPharma

Wednesday, June 20, 2012 03:06 PM

ePharmaSolutions, a clinical services and technology solutions provider, has acquired Polaris BioPharma Consulting, a global patient recruitment and retention firm based in Slough, U.K., to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies.

More... »

Cetero sold to investor group, renamed PRACS Institute

Wednesday, June 20, 2012 02:38 PM

Cary, N.C.-based Cetero Research has finalized the sale of the company to its investor group, led by Freeport Financial, following the company’s Chapter 11 bankruptcy filing court approval of the sale.

More... »

Standardized trial endpoints to help health authorities tackle respiratory diseases

Wednesday, June 20, 2012 12:16 PM

Science is standardizing the way respiratory health is measured, helping to judge the effectiveness of drug treatments better than ever, according to a new report by healthcare experts GBI Research.

More... »